Related Experiment Videos
Third trimester chemotherapy and neonatal hematopoiesis
Cancer Chemotherapy and Pharmacology
|January 1, 1987
Summary
This case study reports on an 18-year-old woman experiencing severe pancytopenia after chemotherapy during pregnancy. The infant was born with normal blood counts, highlighting safe delivery outcomes.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Pediatrics
Background:
- Severe pancytopenia in pregnancy can arise from various causes, including chemotherapy.
- Chemotherapy administered during the third trimester poses potential risks to both mother and fetus.
- Maternal hematologic conditions necessitate careful consideration of delivery methods.